Optimized ChIP-seq procedure facilitates hormone receptor profiling in human tumors
Ontology highlight
ABSTRACT: Performing ChIP-seq analyses in clinical specimens has remained largely challenging due to multiple technical limitations and low quantities of starting material, resulting in low enrichments and poor signal-to-noise ratio. Here, we refined the original protocols for transcription factor ChIP-seq analyses in breast, prostate, and endometrial tumor tissue. In addition to the standard fixative formaldehyde, a second crosslinker Disuccinimidyl glutarate (DSG) was included in the procedure.
ORGANISM(S): Homo sapiens
PROVIDER: GSE114737 | GEO | 2018/12/27
REPOSITORIES: GEO
ACCESS DATA